UK HSE posts guidance on controlling occupational exposure to manufactured nanomaterials
Including carbon nanotubes (CNTs) and other bio-persistent high aspect ratio nanomaterials (HARNs)
The UK's Health and Safety Executive (HSE) has posted a guidance document describing how to control occupational exposure to manufactured nanomaterials in the workplace.
HSE states that "the guidance is specifically about the manufacture and manipulation of all manufactured nanomaterials, carbon nanotubes (CNT), and other bio-persistent high aspect ratio nanomaterials (HARNs" and that "it has been prepared in response to emerging evidence about the toxicity of these materials".
According to HSE, the control principles described in the guidance can be applied to all nanomaterials used in the workplace. HSE highlights any differences in the approach between control of CNTs and other bio-persistent HARNs to other types of nanomaterials.
The guidance describes how to control occupational exposure to manufactured nanomaterials in the workplace. It helps in understanding what needs to do be done to comply with the Control of Substances Hazardous to Health Regulations 2002 (COSHH) (as amended) when working with these substances.
If working with nanomaterials this guidance helps protect employees. If running a medium-sized or large business, where decisions about controlling hazardous substances are more complex, professional advice may also be needed. This guidance is also useful for trade union and employee health and safety representatives.
The control principles described can be applied to all nanomaterials used in the workplace. Any differences in the approach between control of CNTs and other bio-persistent HARNs to any other type of nanomaterials are highlighted in the text.
Source: HSE /...
The Institute of Nanotechnology puts significant effort into ensuring that the information provided on its news pages is accurate and up-to-date. However, we cannot guarantee absolute accuracy. Consequently, the Institute of Nanotechnology disclaims any and all responsibility for inaccuracy, omission or any kind of deficiency in relation to the news items and articles hosted herein.
- 04 March 2014NanoCelluComp presents final results at JEC Europe 2014
- 17 February 2014Researchers Hijack Cancer Migration Mechanism to “Move” Brain Tumours
- 12 February 2014Fingerprinting meningitis with lasers
- 06 February 2014European Innovation Convention 2014
- 30 January 2014NanoSafety Cluster Newsletter No.2 - Out Now
- View All